Use of recombinant human chorionic gonadotropin in ovulation induction

Fertility and Sterility

Volumn 79, Issue 5, 2003, Pages 1051-1059

  Ludwig, Michael ^a   Doody, Kevin J ^a,b   Doody, Kathleen M ^a,b  

^a ENDOKRINOLOGIKUM HAMBURG   (Germany)

^b Center for Assisted Reproduction   (United States)

Author keywords

Final follicular maturation; Ovidrel; Ovitrelle; Recombinant hCG

Indexed keywords

CHORIONIC GONADOTROPIN; LEUPRORELIN; NAFARELIN ACETATE; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN;

CELL COUNT; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG PURITY; DRUG TOLERABILITY; FERTILIZATION; FERTILIZATION IN VITRO; HISTORY OF MEDICINE; HUMAN; INFERTILITY THERAPY; INFLAMMATION; INJECTION PAIN; INJECTION SITE; INTRAUTERINE INSEMINATION; LUTEAL PHASE; META ANALYSIS; NONHUMAN; OOCYTE; OOCYTE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; PUBLICATION; REVIEW; SEXUAL INTERCOURSE; TREATMENT OUTCOME; URINE;

EID: 0037624723     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00173-0     Document Type: Review

References (29)

1. Mazer C, Ravetz E. Am J Obstet Gynecol. 41:1941;474-484.
2. Gemzell C. Induction of ovulation with human gonadotropins. Recent Progr Horm Res. 21:1965;179-204.
3. Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures results of a multicenter double-blind study . J Clin Endocrinol Metab. 86:2001;2607-2618.
4. Abdalla H.I., Ah-Moye M., Brinsden P., Howe D.L., Okonofua F., Craft I. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program. Fertil Steril. 48:1987;958-963.
5. Wikland M., Borg J., Forsberg A.S., Jakobsson A.H., Svalander P., Waldenstrom U. Human chorionic gonadotrophin self-administered by the subcutaneous route to induce oocyte maturation in an in-vitro fertilization and embryo transfer programme. Hum. Reprod. 10:1995;1667-1670.
6. Scott R.T., Hofmann G.E., Muasher S.J., Acosta A.A., Kreiner D.K., Rosenwaks Z. Correlation of follicular diameter with oocyte recovery and maturity at the time of transvaginal follicular aspiration. J In Vitro Fert Embr Transf. 6:1989;73-75.
7. Ectors F.J., Vanderzwalmen P., Van Hoeck J., Nijs M., Verhaegen G., Delvigne A., et al. Relationship of human follicular diameter with oocyte fertilization and development after in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod. 12:1997;2002-2005.
8. Andersen A.G., Als-Nielsen B., Hornnes P.J., Franch A.L. Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Hum Reprod. 10:1995;3202-3205.
9. Fischer R.A., Nakajima S.T., Gibson M., Brumsted J.R. Ovulation after intravenous and intramuscular human chorionic gonadotropin. Fertil Steril. 60:1993;418-422.
10. Mansour R.T., Aboulghar M.A., Serour G.I. Study of the optimum time for human chorionic gonadotropin-ovum pickup interval in in vitro fertilization. J Assist Reprod Gen. 11:1994;478-481.
11. Agrawal R., West C., Conway G.S., Page M.L., Jacobs H.S. Pregnancy after treatment with three recombinant gonadotropins. Lancet. 349:1997;29-30.
12. Cochius J.I., Burns R.J., Blumbergs P.C., Mack K., Alderman C.P. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust NZ J Med. 20:1990;592-593.
13. Dumble L.J., Klein R.D. Creutzfeldt-Jakob legacy for Australian women treated with human pituitary gonadotropins. Lancet. 340:1992;847-848.
14. Albano C., Smitz J., Camus M., Bennink H.C., Van Steirteghem A.C., Devroey P. Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin. Hum Reprod. 11:1996;1632-1634.
15. Whitman-Elia G.F., Banks K., O'Dea L.S. Recombinant follicle-stimulating hormone in a patient hypersensitive to urinary-derived gonadotrophins. Gynecol Endocrinol. 12:1998;209-212.
16. Esposito M.A., Patrizio P. Partial follicular aspiration for salvaging an IVF cycle after improper hCG administration. A case report. J Reprod Med. 45:2000;511-514.
17. Quintans C.J., Donaldson M.J., Blanco L.A., Pasqualini R.S. Empty follicle syndrome due to human errors its occurrence in an in-vitro fertilization programme . Hum Reprod. 13:1998;2703-2705.
18. Zegers Hochschild F., Fernandez E., Mackenna A., Fabres C., Altieri E., Lopez T. The empty follicle syndrome a pharmaceutical industry syndrome . Hum Reprod. 10:1995;2262-2265.
19. Penarrubia J., Balasch J., Fabregues F., Creus M., Civico S., Vanrell A. Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gonadotrophin. Hum Reprod. 14:1999;1703-1706.
20. Ndukwe G., Thornton S., Fishel S., Dowell K., Aloum M., Green S. "Curing" empty follicle syndrome. Hum Reprod. 12:1997;21-23.
21. Salha O., Dada T., Sharma V. Influence of body mass index and self-administration of hCG on the outcome of IVF cycles a prospective cohort study . Hum Fertil (Camb). 4:2001;37-42.
22. Trinchard-Lugan I., Khan A., Porchet H.C., Munafo A. Pharmakokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers. Reprod Biomed Online. 4:2002;106-115.
23. Duffy D.M., Hutchinson J.S., Stewart D.R., Stouffer R.L. Stimulation of primate luteal function by recombinant human chorionic gonadotropin and modulation of steroid, but not relaxin, production by an inhibitor of 3 beta-hydroxysteroid dehydrogenase during stimulated early pregnancy. J Clin Endocrinol Metab. 81:1996;2307-2313.
24. Zelinski-Wooten M.B., Hutchison J.S., Trinchard-Lugan I., Hess D.L., Wolf D.P., Stouffer R.L. Initiation of periovulatory events in gonadotrophin-stimulated macaques with varying doses of recombinant human chorionic gonadotrophin. Hum Reprod. 12:1997;1877-1885.
25. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertil Steril 2001;75:1111-8.
26. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment - rhCG versus urinary hCG. Hum Reprod. 15:2000;1446-1451.
27. Driscoll G.L., Tyler J.P., Hangan J.T., Fisher P.R., Birdsall M.A., Knight D.C. A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum Reprod. 15:2000;1305-1310.
28. Chang P., Kenley S., Burns T., Currie K., DeVane G., O'Dea L. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization - embryo transfer . Fertil Steril. 76:2001;67-74.
29. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment - recombinant hCG versus urinary hCG. Hum Reprod. 15:2000;1446-1451.